Home Alder Biopharmaceuticals

Alder Biopharmaceuticals

acquired
Post-IPO Round
Biopharmaceutical Company
Basic
Enterprise Profile

Basic Information

Alder Biopharmaceuticals is a biopharmaceutical company that uses its proprietary technology to uniquely identify, develop, manufacture, and commercialize its own antibody therapies, which can help people suffering from cancer, autoimmune diseases, and inflammatory conditions.
Alder BioPharmaceuticals, Inc.
Washington,United States of America
51~100 people
January 01, 2004
info@alderbio.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Tumor Immune System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Prescription Drug Monoclonal Antibody